Ophthalmic Business News

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, John A. Hovanesian, MD, FACS, discusses Healio’s Eyeluminaries podcast, featuring eye care’s visionaries and newsmakers.

In the third part of a 12-part series, Peter J. Polack, MD, FACS, explains the potential benefits of marketing for a practice.

In the second part of a 12-part series, Peter J. Polack, MD, FACS, provides a brief overview of marketing strategies and tactics for practices.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, CEO Ryan Bleeks introduces Visiox Pharma to the ophthalmic biopharmaceutical market and outlines some of the products in the company’s pipeline.

In this Healio Video Perspective, Bill Carpou, CEO of Octane, previews this year’s Ophthalmology Technology Summit, including a special session for ophthalmologists on how to join industry boards.

Byooviz, a biosimilar referencing Lucentis, has been launched in the United States and will be commercially available on July 1, according to a press release.

Ocular Therapeutix is making changes to its senior leadership team, according to a press release.

The Bloomberg U.S. Aggregate Bond Index experienced its worst-performing quarter in more than 40 years, losing 5.93% from January to March.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective, Eric D. Donnenfeld, MD, discusses why eye care specialists should attend the Kiawah Eye meeting.

Outlook Therapeutics is withdrawing its biologics license application for ONS-5010 for the treatment of wet age-related macular degeneration after the FDA requested more information, according to a press release.